It's Time for True Advances in Comparative Effectiveness Research
December 21, 2015
It is simply unrealistic and highly counterproductive to the future of cancer care to believe that the
only acceptable approach to determining the absolute or relative clinical utility of a specific drug,
regimen, device, or procedure, is through the conduct of a so-called evidence-based randomized trial.